Drug · DIN 02229422
NIMBEX
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since June 7, 2016; first marketed March 17, 1997.
- Drug Identification Number (DIN)
- 02229422
- Company (DIN owner)
- AbbVie CorporationSaint-Laurent, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Liquid
- Route
- Intravenous
- Therapeutic class (ATC)
- Cisatracurium M03AC11
- Class
- Human
- Record last updated
- June 17, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| CISATRACURIUM (CISATRACURIUM BESYLATE) | 2 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 1, 2012: NOC 13789New Drug Submission (NDS) · Manufacturer name change
- March 21, 2000: NOC 1066Supplement to a New Drug Submission (SNDS) · Product monograph update - for use during coronary artery bypass graft surgery
- February 24, 2000: NOC 1072New Drug Submission (NDS)
- December 18, 1996: NOC 4323New Drug Submission (NDS)